Drug

Belantamab Mafodotin

63 flagged reaction(s) · 4,081 total co-reports · max PRR 170.2

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Visual Acuity Reduced	773	170.2	231.4	signal
2	Plasma Cell Myeloma	431	80.3	94.1	signal
3	Photophobia	187	72.9	77.8	signal
4	Dry Eye	393	58.9	67.9	signal
5	Ocular Discomfort	45	30.0	30.4	signal
6	Hospice Care	37	27.2	27.5	signal
7	Eye Disorder	87	19.2	19.7	signal
8	Diplopia	64	17.8	18.2	signal
9	Hypercalcaemia	29	17.0	17.1	signal
10	Blindness	86	15.2	15.7	signal
11	Cataract	112	13.6	14.1	signal
12	Therapy Partial Responder	27	12.9	13.0	signal
13	Cytokine Release Syndrome	30	11.4	11.5	signal
14	Lacrimation Increased	41	9.9	10.0	signal
15	Vision Blurred	186	9.8	10.4	signal
16	Covid-19 Pneumonia	15	9.1	9.1	signal
17	Cytopenia	14	8.4	8.5	signal
18	Thrombocytopenia	118	7.6	7.9	signal
19	Myelodysplastic Syndrome	15	7.5	7.5	signal
20	Visual Impairment	126	7.4	7.7	signal
21	Pneumocystis Jirovecii Pneumonia	10	7.2	7.2	signal
22	Eye Pain	49	6.4	6.5	signal
23	Haematotoxicity	8	6.2	6.2	signal
24	Bacteraemia	10	6.1	6.1	signal
25	Blood Lactate Dehydrogenase Increased	13	5.9	5.9	signal
26	Liver Function Test Increased	17	5.7	5.8	signal
27	Polyneuropathy	9	5.5	5.5	signal
28	Disease Progression	88	5.4	5.5	signal
29	Photosensitivity Reaction	12	5.3	5.3	signal
30	Eye Irritation	37	4.8	4.8	signal
31	Death	570	4.8	5.7	signal
32	Decreased Immune Responsiveness	6	4.4	4.4	signal
33	Bone Pain	36	4.4	4.5	signal
34	Immunodeficiency	9	4.4	4.4	signal
35	Sars-cov-2 Test Positive	8	4.3	4.3	signal
36	Conjunctivitis	11	4.3	4.3	signal
37	Neurotoxicity	10	4.1	4.2	signal
38	Platelet Count Decreased	58	3.9	4.0	signal
39	Cytomegalovirus Infection	9	3.9	3.9	signal
40	Drug Effect Less Than Expected	7	3.6	3.6	signal
41	Transfusion	5	3.4	3.4	signal
42	Pancytopenia	25	3.2	3.3	signal
43	Neoplasm Progression	15	3.1	3.1	signal
44	Hospitalisation	63	3.0	3.0	signal
45	Apathy	6	3.0	3.0	signal
46	Ocular Hyperaemia	19	2.9	2.9	signal
47	Basal Cell Carcinoma	6	2.8	2.8	signal
48	Eye Haemorrhage	5	2.7	2.7	no signal
49	Eye Pruritus	12	2.6	2.6	signal
50	Central Nervous System Lesion	5	2.6	2.6	no signal
51	Neutropenia	48	2.6	2.6	signal
52	Subdural Haematoma	5	2.5	2.5	no signal
53	Malignant Neoplasm Progression	34	2.4	2.4	signal
54	Hepatic Cytolysis	4	2.4	2.4	no signal
55	Brain Neoplasm	3	2.4	2.4	no signal
56	Retinal Detachment	3	2.4	2.4	no signal
57	Malignant Melanoma	4	2.1	2.1	no signal
58	Dialysis	4	2.0	2.0	no signal
59	Haemorrhage Intracranial	4	1.9	1.9	no signal
60	Acute Myeloid Leukaemia	4	1.9	1.9	no signal
61	Sleep Disorder Due To A General Medical Condition	4	1.8	1.8	no signal
62	Incorrect Product Administration Duration	4	1.4	1.4	no signal
63	Myelosuppression	6	1.3	1.3	no signal